Klercide™ IPA Product Range Now Authorised By The BPR
Ecolab’s Klercide™ 70/30 IPA and Klerwipe™ 70/30 IPA ranges are now authorised under the Biocidal Products Regulation (BPR) effective 9th March 2023.
Our Range of Peroxide Products Will Give Customers the Assurance Of:
Klercide™ IPA Product Range Gains BPC Positive Opinion
Ecolab’s Klercide™ 70/30 IPA range has recently completed the most critical milestone in the BPR approval process. This is a very key step towards full BPR authorisation.
- Free movement of these products and their availability across the European market
- Validated product efficacy
- Compliant manufacturing processes
- A range of formats
- Avoidance of product withdrawal
- The patented SteriShield™ Delivery System (SDS) for the 1L ready to use trigger sprays
For further information on the impact for our customers on the BPC approval, contact us.
The BPR EU 528/2012
The BPR replaced the Biocidal Product Directive (BPD) on 1st September 2013 as the legislation responsible for placing biocidal active substances and products on the European Market.
As a regulation, it became legally binding for countries that fall within the scope of EU regulations — all European Union countries as well as Iceland, Liechtenstein, Norway and Switzerland (the European Free Trade Association countries).
The BPR offers a harmonised, centralised authorisation option for biocidal products at a European level versus the BPD.
The BPR is designed to control the use of, and the placing on the market of biocidal products. It involves an assessment of a biocidal product’s efficacy, toxicity, and the risk during use. Additionally, it requires robust data to prove the effectiveness and safety of the biocidal product, as well as a list of approved biocidal active substances and suppliers.
The BPR Threefold Objective
Harmonization and free movement
of biocidal products within
the European market
A high level of protection to
human health, animal health
and the environment
To ensure that only authorized
products with acceptable
efficacy remain on the EU market
All Life Sciences manufacturers must ensure that biocidal products supplied for use in their manufacturing sites, are registered in the relevant country of operation, purchased from an approved source as per Article 95 of the BPR and any disinfectants used on site are subject to BPR registration. This is where our team of Regulatory experts can help you.